Vial · 4 months ago
Software Engineer Intern (Jan - April 2026) - United States
United States
Internship
Hybrid
Intern
$25/hr - $30/hr
1+ years exp
Start in 2026 WinterVial is a hyper-scalable biotech company focused on reimagining drug development to cure human diseases. As a Software Engineering Intern, you will collaborate with a team to build end-to-end products that support clinical trials, contributing to the technical vision and architecture of the company.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Collaborating with the team to establish Vial's technical vision and architecture
Building applications end-to-end using a combination of traditional software development frameworks and low/no-code tools
Writing well-crafted, well-tested, readable, and maintainable code and documentation
Providing input on the product roadmap and future plans
Participate in the development of large-scale projects at all stages of the software development lifecycle
Continuously learn and improve your skills. This includes staying up to date with the latest industry trends, technologies, and best practices
Qualification
Required
1-2 years of experience with full stack engineering (internships, side projects, etc.)
Experience working with Javascript and widely adopted libraries/frameworks (ie React, Express)
Experience working with one or more general purpose programming languages (TypeScript, Python, C#, etc)
Ability to work full time, 40 hours a week during US / Canada working hours (EST or PST)
History of shipping high quality products and features at scale
Knowledgeable about modern web technologies and testing frameworks
Experience working with databases
Ability to pick up new tools quickly
Preferred
Entrepreneurial mindset, experience in startup environment preferred
Experience with healthcare or clinical trials is a plus
New graduates welcome and encouraged to apply
Benefits
Accrued Personal Time Off (up to 3 days)
Paid Holidays
Remote-First, Flexible Work Schedule
Company provided laptop
Company
Vial
Vial is a hyper scalable biotech — advancing programs into the clinic with lower cost trials and computationally designed therapeutics.
51-200 employees
Funding
Current Stage
Growth StageTotal Funding
$111MKey Investors
ATEL VenturesGeneral CatalystBuckley Ventures
2025-06-18Debt Financing· $10M
2022-11-30Series B· $67M
2022-11-30Series A· $34M
Leadership Team
Simon Burns
Co-Founder
Recent News
Company data provided by crunchbase